| 摘要 |
The present invention relates to compounds of the formula <IMAGE> wherein R1 is selected from the group consisting of hydrogen, lower alkyl, C3 to C7 alkenyl or alkynyl, hydroxymethyl, the group <IMAGE> wherein R11 is hydrogen, hydroxy, alkoxy, amino and mono- or di-lower alkylamino; and R3 is selected from the group consisting of hydrogen, lower alkyl, C3 to C7 alkenyl or alkynyl, hydroxymethyl, the group <IMAGE> wherein R11 is hydrogen, hydroxy, trihalomethyl, alkoxy, amino and mono- or di-lower alkylamino; R2 is selected from the group consisting of hydrogen, lower alkyl, C3 to C7 alkenyl or alkynyl, the group <IMAGE> C2 to C7 carboxylic acids and the esters and amides thereof, hydroxy C2 to C7 alkyl and amino or mono- or di-lower alkyl amino C2 to C7 alkyl; R4 is selected from the group consisting of hydrogen, acyloxy, straight chain lower alkoxy and hydroxy; R5 is halogen or hydrogen; R6 is halogen with the proviso that if one of R1 or R3 is hydroxymethyl or the group <IMAGE> wherein R11 is as above then the remaining substituent is selected from the group consisting of hydrogen, lower alkyl and C3 to C7 alkenyl or alkynyl, and R2 is hydrogen and the further proviso that (A) when R4 is acyloxy then R1 and R3 are hydrogen, lower alkyl, C3 to C7 alkenyl or C3 to C7 alkynyl, and R2 is the group <IMAGE> (B) when R4 is hydroxy then R1 and R3 are hydrogen, lower alkyl, C3 to C7 alkenyl or C3 to C7 alkynyl, and R2 is hydrogen or (C) when R4 is alkoxy then R1 and R3 are hydrogen, lower alkyl, C3 to C7 alkenyl or C3 to C7 alkynyl, and the pharmaceutically acceptable salts thereof. Also disclosed are certain 5,6 dihydro derivatives, N-oxides and quarternary iminium salts of the pyrrolobenzazepines.
|
